Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-15
2005-02-15
Spivack, Phyllis (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S250000
Reexamination Certificate
active
06855707
ABSTRACT:
Disclosed are methods for modifying or regulating at least one of glucose or lipid metabolism disorders which comprises administering to a human or vertebrate subject a D1dopamine agonist in conjunction with a dopamine D2agonist where the conjoined administration is effective to improve at least one of the following lipid and glucose metabolic indices: body weight, body fat, plasma insulin, plasma glucose and plasma lipid, and plasma lipoprotein. In preferred embodiments, the administration of the D1dopamine agonist and the D2dopamine agonist is conducted at a predetermined time.
REFERENCES:
patent: 3074847 (1963-01-01), Bigsby et al.
patent: 3752814 (1973-08-01), Fluckiger et al.
patent: 3752888 (1973-08-01), Fluckiger et al.
patent: 3922347 (1975-11-01), Bach et al.
patent: 4054660 (1977-10-01), Clemens et al.
patent: 4239763 (1980-12-01), Milavec et al.
patent: 4659715 (1987-04-01), Meier et al.
patent: 4749709 (1988-06-01), Meier et al.
patent: 4783469 (1988-11-01), Meier et al.
patent: 5006526 (1991-04-01), Meier et al.
patent: 5468755 (1995-11-01), Cincotta et al.
patent: 890369 (1982-03-01), None
patent: 2192541 (1988-01-01), None
patent: 57-8231 (1980-09-01), None
Jackson et al., Journal of Neural Transmission, 69(1-2) 131-45 (1987) (abstract).*
Kotani et al., Japanese J. Pharmacology, 54, (1990),482-486.*
Barnett,Post Graduate Medical J.,56:11-14 (1980).
Bartness et al.,J. Exp. Zoology,244:437-454 (1987).
Berle,Acta endocr.,Suppl. 173, Abstract No. 104 (1973).
Brus, et al., “Modulation of Glucose Uptake in Rat Brain After Administration of Quinpirole and SKF-38393, Two Central Dopamine-Receptor Agonists”,Pharmacology Communications,7:87-91 (1995).
Burns et al.,Int'l. Symp. on Chronopharm and Chronother(1988).
Cassar, J. et al. “Bromocriptine Treatment of Acromegaly,”Metabolism,26: 539-546 (1977).
Chemical Abstracts, 109:66888W (1988).
Chemical Abstracts, 112:75773U (1990).
Cincotta et al.,J. Endocrinol,106:177-181 (1985).
Cincotta et al.,J. Endocrinol,106:173-176 (1985).
Cincotta et al.,Life Sciences,45:2247-2254 (1989).
Cincotta,J. Endocrinol,103:141-146 (1984).
Cincotta et al.,J. Endocrinol,120:385-391 (1989).
Cincotta et al.Ann Nutr Metab,33:305-314 (1989).
Cincotta et al.,Experientia,43:416-417 (1987).
Cincotta et al.,Horm Metabol Res,21:64-68 (1989).
De Mattia et al.,La Clinica Terapeutica,vol. XI (1983).
Dolocek, R. et al. “Bromocriptine and glucose tolerance in acromegalics,”Pharmatherapeutica3:100-106 (1982).
Eisemann et al.,J. of Animal Sci,59:95-104 (1984).
Eisemann et al.,J. of Animal Sci,59:86-94 (1984).
Emata et al.,J. Exp. Zoology,233:29-34 (1985).
Eskildsen, P.C. et al., “Long-Term Treatment of Acromegaly with Bromocriptine”,Acta Endocr.87: 687-700 (1978).
Goldstein, M., EMBASE Abstract No. 90266123,Psychopharmacol. Bull,25/3:349-352 (1989).
Harel et al.,Proc. La. Acad. Sci.,38:125 (1975).
Horseman et al.,General and Comparative Endocrinology,38:269-274 (1979).
Horseman et al.,J. Endocr,82:367-372 (1979).
Joseph et al.,J. Exp. Zool,178:59-62 (1971).
Joseph et al.,Proc. Soc. Exp. Bio. Med.,146:1150-1155 (1974).
Komorowski et al.,Aliment. Nutr. Metab,1:293 (1980).
Landgraf et al.,Deutschen Gessellschaft fur innere Medizin(Apr. 25-25, 1976).
Larson et al.,Lakartidningen,82:4425 (1985).
Lee et al.,J. Exp. Zool,166:307-316 (1967).
Lobato et al.Mol. and Cell. Biochem,67:19-23 (1985).
Martin et al.,The Condor,75: 369-374 (1973).
Martin et al.,Neuroendocrinology,52: 9-14 (1990).
Martin et al.,Chronobiology,641-646 (1974).
Martin et al.,Proc. La. Acad. Sci.,38:127 (1975).
Martin et al.,Ame Zoologist,18:572 (1978).
Martin, Dissertation LSU (1974).
Martin, Thesis, Sam Houston State College (1969).
Meier,Amer. Scientist,61:184-187 (1973).
Meier et al.,Biology of Reproduction,8:400-410 (1973).
Meier et al.,General and Comparative Endocrinology,26:253-258 (1975).
Meier et al.,General and Comparative Endocrinology,3:499-508 (1972).
Meier et al.,Proc. Soc. Exp. Biol. and Med.,133:1113-16 (1970).
Meier et al.,Science,173:1240-42 (1971).
Meier et al.,Gen.&Comp. Endocrin,17:311-318 (1971).
Meier et al.,Proc. Soc. for Exp. Bio.&Med,137:408-415 (1971).
Meier et al.,Gen.&Comp. Endocrin,8:110-114 (1967).
Meier et al.,Transactions of the American Fisheries Society,113:422-431 (1984).
Meier et al.,Current Ornithology,2:303-343 (1984).
Meier et al., Circadian hormone basis for seasonal conditions in the gulf killifish “Fundus grandi”,InComparative Endocrinology,pp. 141-144. Galliard et al. (eds), Elsevier/North Holland Biomedical Press, Amsterdam (1978).
Meier et al.,Amer. Zool,16:649-659 (1976).
Meier et al.,Amer. J. of Physiology,232:E193-E196 (1977).
Meier et al.,Experientia,48:248-253 (1992).
Meier et al.,Physiol. Zool,41:95-103 (1968).
Miller et al.,J. Interdiscipl. Cycle Res.,14:75-84 (1983).
Miller et al.,J. Interdiscipl. Cycle Res.,14:85-94 (1982).
Moore et al.,Biology of Reproduction,36:47-58 (1987).
Ottenweller et al.,Life Sciences,28:1033-1040 (1981).
Spieler et al.,Life Sciences,22:255-258 (1977).
Southern et al.,J. Animal Sci.,68:931-936 (1990).
Steinbeck, K. and J.R Turtle, “Treatment of Acromegalywith Bromocryptine,”Aust. N.Z. J. Med.9: 217-224 (1979).
Thomas et al.,Sem. des Hosp. de Paris,53(34-35):1857-1862 (1977).
Tozzo, et al, “Diabetes”, 45(Suppl. 2):105A (1996).
Wass, J.A.H. et al. “An Assessment of Glucose Intolerance In Acromegaly and Its Response to Medical Treatment,”Clin. Endocr.,12: 53-59 (1980).
Wilson,Chrono. Bio. Int.6:113-121 (1989).
Phillips et al.,Psychopharmacology,117:82-90 (1995).
Saller et al.,Brain Research,546:235-250 (1991).
Bordi et al.,Faseb Journal,vol. 3 (1989).
Laudrelle et al.,Fundamental&Clinical Pharmacology,5:481-490 (1991).
Terry et al.,Obesity Research,3:515S-523S (1995).
Zarrindast et al.,General Pharmacology,22:1011-1016 (1991).
Samanin et al.,Therapie,51:107-115 (1996).
Samanin et al.,Pharmacology&Toxicology,73:63-68 (1993).
Wellman,American Journal of Clinical Nutrition,55:193S-198S, (1992).
Pliva D.D.
Spivack Phyllis
LandOfFree
Method for the treatment of lipid and glucose metabolism... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of lipid and glucose metabolism..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of lipid and glucose metabolism... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3498146